Should You Hold Phathom Pharmaceuticals Inc (PHAT) in Biotechnology Industry?

Phathom Pharmaceuticals Inc (PHAT) is around the top of the Biotechnology industry according to InvestorsObserver. PHAT received an overall rating of 63, which means that it scores higher than 63 percent of all stocks. Phathom Pharmaceuticals Inc also achieved a score of 82 in the Biotechnology industry, putting it above 82 percent of Biotechnology stocks. Biotechnology is ranked 62 out of the 148 industries.

PHAT has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on PHAT!

See Full PHAT Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Phathom Pharmaceuticals Inc Stock Today?

Phathom Pharmaceuticals Inc (PHAT) stock is trading at $8.95 as of 1:21 PM on Monday, Oct 30, an increase of $0.29, or 3.35% from the previous closing price of $8.66. The stock has traded between $8.75 and $9.27 so far today. Volume today is below average. So far 267,586 shares have traded compared to average volume of 370,414 shares. Click Here to get the full Stock Report for Phathom Pharmaceuticals Inc stock.